Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016

Although schizophrenia is a low prevalence disorder, the burden of disease is substantial. Our modeling suggests that significant population growth and aging has led to a large and increasing disease burden attributable to schizophrenia, particularly for middle income countries.